6.91
-0.38(-5.21%)
Currency In USD
| Previous Close | 7.29 |
| Open | 7.28 |
| Day High | 7.44 |
| Day Low | 6.9 |
| 52-Week High | 8.8 |
| 52-Week Low | 1.03 |
| Volume | 2.22M |
| Average Volume | 1.98M |
| Market Cap | 768.81M |
| PE | -5.44 |
| EPS | -1.27 |
| Moving Average 50 Days | 7.06 |
| Moving Average 200 Days | 4 |
| Change | -0.38 |
If you invested $1000 in Tango Therapeutics, Inc. (TNGX) since IPO date, it would be worth $675.46 as of October 08, 2025 at a share price of $6.91. Whereas If you bought $1000 worth of Tango Therapeutics, Inc. (TNGX) shares 3 years ago, it would be worth $1,697.79 as of October 08, 2025 at a share price of $6.91.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tango Therapeutics to Present First Clinical Data from TNG260 at Society for Immunotherapy of Cancer (SITC) Annual Meeting 2025
GlobeNewswire Inc.
Oct 06, 2025 11:00 AM GMT
Company to present three posters at SITC Annual Meeting 2025BOSTON, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of pre
Tango Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference
GlobeNewswire Inc.
Aug 26, 2025 11:00 AM GMT
BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at the 2025 Can
Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025
GlobeNewswire Inc.
Jul 22, 2025 11:00 AM GMT
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that it will report second quarter 2025 financial results on August 5, 2025, before the open of the U.S. financial markets. The company does not inte